NCT07022067

EVOLVING AZIMUTH IN MUSA CONTEXT

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 184 (estimated)
• Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure

Detailed description

The patient diagnosed with heart failure is randomized to either the experimental or control arm. The patient in the experimental arm downloads a telemonitoring application where they enter their pressure and body weight data, which is revised by the hospital team via a platform. Patients from both arms complete a questionnaire during enrollment and during two follow-ups (3 months and 6 months) to examine various dimensions.

Conditions

• Heart Failure
• Blood Pressure
• Weight Change
• Telemonitoring

Interventions

Type	Name	Description
DEVICE	Telemonitoring app	periodic measurement of blood pressure and body weight

Timeline

• Start date: 2024-10-02
• Primary completion: 2025-06-30
• Completion: 2025-08-31
• First posted: 2025-06-15
• Last updated: 2025-06-15

Locations

1 site across 1 country: Italy